115 related articles for article (PubMed ID: 36323327)
21. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
22. Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer.
Kamigaichi A; Tsutani Y; Fujiwara M; Mimae T; Miyata Y; Okada M
Clin Lung Cancer; 2019 Sep; 20(5):397-403.e1. PubMed ID: 31281050
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy.
Moretti L; Yu DS; Chen H; Carbone DP; Johnson DH; Keedy VL; Putnam JB; Sandler AB; Shyr Y; Lu B
Oncologist; 2009 Nov; 14(11):1106-15. PubMed ID: 19897534
[TBL] [Abstract][Full Text] [Related]
24. Wedge bronchoplastic lobectomy for non-small cell lung cancer as an alternative to sleeve lobectomy.
Park SY; Lee HS; Jang HJ; Joo J; Kim MS; Lee JM; Zo JI
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):825-831.e3. PubMed ID: 22104687
[TBL] [Abstract][Full Text] [Related]
25. Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy.
Tsutani Y; Kagimoto A; Handa Y; Mimae T; Miyata Y; Okada M
Jpn J Clin Oncol; 2019 Dec; 49(12):1134-1142. PubMed ID: 31602468
[TBL] [Abstract][Full Text] [Related]
26. Oncological outcomes of sublobar resection for clinical-stage IA high-risk non-small cell lung cancer patients with a radiologically solid appearance on computed tomography.
Hattori A; Takamochi K; Matsunaga T; Oh S; Suzuki K
Gen Thorac Cardiovasc Surg; 2016 Jan; 64(1):18-24. PubMed ID: 26486132
[TBL] [Abstract][Full Text] [Related]
27. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.
Hung JJ; Jeng WJ; Hsu WH; Chou TY; Huang BS; Wu YC
J Thorac Oncol; 2012 Jul; 7(7):1115-23. PubMed ID: 22592210
[TBL] [Abstract][Full Text] [Related]
28. Risk Factors of Recurrence in Patients With Clinical Stage IA Adenocarcinoma Presented as Ground-Glass Nodule.
Su H; Dai C; Xie H; Ren Y; She Y; Kadeer X; Xie D; Zheng H; Jiang G; Chen C
Clin Lung Cancer; 2018 Sep; 19(5):e609-e617. PubMed ID: 29803575
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors and clinical outcome in patients with surgically resected peripheral N0 adenocarcinoma <3 cm.
Luzzi L; Marulli G; DE Palma A; Meniconi F; Ghisalberti M; Stocca F; Pagliarulo V; Loizzi M; Rea F; Gotti G
Minerva Chir; 2016 Feb; 71(1):1-7. PubMed ID: 26149520
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of segmentectomy and wedge resection for pulmonary metastases from colorectal cancer.
Shiono S; Okumura T; Boku N; Hishida T; Ohde Y; Sakao Y; Yoshiya K; Hyodo I; Mori K; Kondo H
Eur J Cardiothorac Surg; 2017 Mar; 51(3):504-510. PubMed ID: 27773868
[TBL] [Abstract][Full Text] [Related]
31. Lung resection for recurrence after pneumonectomy for metastases.
Grunenwald D; Spaggiari L; Girard P; Baldeyrou P; Posea R; Lamer C; Bourel P; Le Chevalier T
Bull Cancer; 1997 Mar; 84(3):277-81. PubMed ID: 9207874
[TBL] [Abstract][Full Text] [Related]
32. Fate of newly detected lesions during postoperative surveillance for non-small cell lung cancer.
Lee JI; Lee YJ; Park KY; Park CH; Jeon YB; Choi CH; Ko KP
Ann Thorac Surg; 2013 Jun; 95(6):1867-71. PubMed ID: 23643548
[TBL] [Abstract][Full Text] [Related]
33. Bronchial resection margin length and clinical outcome in non-small cell lung cancer.
Tomaszek SC; Kim Y; Cassivi SD; Jensen MR; Shen KH; Nichols FC; Deschamps C; Wigle DA
Eur J Cardiothorac Surg; 2011 Nov; 40(5):1151-6. PubMed ID: 21450488
[TBL] [Abstract][Full Text] [Related]
34. Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial.
Su S; Scott WJ; Allen MS; Darling GE; Decker PA; McKenna RJ; Meyers BF
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):747-52: Discussion 752-3. PubMed ID: 24290575
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic features of resected subcentimeter lung cancer.
Sakurai H; Nakagawa K; Watanabe S; Asamura H
Ann Thorac Surg; 2015 May; 99(5):1731-8. PubMed ID: 25825199
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
[TBL] [Abstract][Full Text] [Related]
37. ["Intentionally" limited pulmonary resection versus lobectomy for the treatment of peripheral stage IA non-small cell lung cancers].
Mondello B; Sibilio M; Pavone A; Monaco F; Nunnari F; Micali V; Vasta I; Perrone O; Monaco M
G Chir; 2007; 28(1-2):7-12. PubMed ID: 17313726
[TBL] [Abstract][Full Text] [Related]
38. Preoperative biopsy does not affect postoperative outcomes of resectable non-small cell lung cancer.
Taniguchi Y; Fukumoto K; Matsui H; Saito T; Murakawa T
Gen Thorac Cardiovasc Surg; 2019 Jul; 67(7):615-623. PubMed ID: 30659509
[TBL] [Abstract][Full Text] [Related]
39. Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer.
Kodama K; Higashiyama M; Okami J; Tokunaga T; Imamura F; Nakayama T; Inoue A; Kuriyama K
Ann Thorac Surg; 2016 Feb; 101(2):504-11. PubMed ID: 26542438
[TBL] [Abstract][Full Text] [Related]
40. Wedge resection as an alternative treatment for octogenarian and older patients with early-stage non-small-cell lung cancer.
Mimae T; Miyata Y; Tsutani Y; Imai K; Ito H; Nakayama H; Ikeda N; Okada M
Jpn J Clin Oncol; 2020 Sep; 50(9):1051-1057. PubMed ID: 32577731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
